Table 3.

Logistic regression analysis of CYP1B1 methylation in BPH and prostate cancer

Odds ratio*95% confidence intervalP value
MSP1 (−)7.263.01-15.92<0.001
MSP2 (−)40.4516.96-96.46<0.001
MSP3 (−)25.7912.45-53.44<0.001
MSP5 (−)8.704.63-16.39<0.001
  • NOTE: Logistic regression analysis showed that MSP-positive patients had a significantly lower risk for prostate cancer as compared with MSP-negative patients.

  • * Age adjusted.

  • BPH versus prostate cancer.